Sam McClinton

Medicine & Life Sciences

1. Lithotripsy 100%
2. Systematic Reviews 91%
3. Ureteroscopy 60%
4. Percutaneous Nephrolithotomy 56%
5. Cost-Benefit Analysis 55%
6. Nephrectomy 48%
7. Renal Cell Carcinoma 47%
8. Randomized Controlled Trials 47%
9. Ureter 42%
10. Tamsulosin 40%
11. Kidney Neoplasms 34%
12. Nomograms 34%
13. Meta-Analysis 33%
14. Stress Urinary Incontinence 33%
15. Prostatic Neoplasms 31%
16. Kidney Calculi 30%
17. Costs and Cost Analysis 30%
18. Therapeutics 30%
19. Urinary Incontinence 30%
20. Quality-Adjusted Life Years 30%
21. Kidney 29%
22. Quality of Life 24%
23. Uncertainty 24%
24. Renal Colic 23%
25. Placebos 21%
26. Medication Therapy Management 20%
27. pazopanib 20%
28. Image-Guided Biopsy 20%
29. Adrenalectomy 20%
30. Urinary Bladder Calculi 19%
31. Urologic Neoplasms 19%
32. Practice Guidelines 19%
33. Nephroureterectomy 18%
34. Urinary Calculi 18%
35. Neoplasm Staging 17%
36. Urinary Diversion 17%
37. Transurethral Resection of Prostate 17%
38. Lymph Node Excision 17%
39. Transitional Cell Carcinoma 16%
40. Injections 16%
41. Economics 15%
42. Urology 15%
43. Machine Learning 15%
44. Minimally Invasive Surgical Procedures 15%
45. Cystectomy 15%
46. Urinary Bladder 15%
47. Nifedipine 15%
48. Calcium Channel Blockers 15%
49. National Institutes of Health (U.S.) 14%
50. Back 13%